269 related articles for article (PubMed ID: 9398126)
1. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy.
Bhandari S; Norfolk D; Brownjohn A; Turney J
Am J Kidney Dis; 1997 Dec; 30(6):814-21. PubMed ID: 9398126
[TBL] [Abstract][Full Text] [Related]
2. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
4. Effective utilization of erythropoietin with intravenous iron therapy.
Bhandari S; Brownjohn A; Turney J
J Clin Pharm Ther; 1998 Feb; 23(1):73-8. PubMed ID: 9756115
[TBL] [Abstract][Full Text] [Related]
5. Hypochromic red blood cells and reticulocytes.
Schaefer RM; Schaefer L
Kidney Int Suppl; 1999 Mar; 69():S44-8. PubMed ID: 10084285
[TBL] [Abstract][Full Text] [Related]
6. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
Tsuchiya K; Okano H; Teramura M; Iwamoto Y; Yamashita N; Suda A; Shimada K; Nihei H; Ando M
Clin Nephrol; 2003 Feb; 59(2):115-23. PubMed ID: 12608554
[TBL] [Abstract][Full Text] [Related]
7. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
Park L; Uhthoff T; Tierney M; Nadler S
Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194
[TBL] [Abstract][Full Text] [Related]
8. Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis.
Cullen P; Söffker J; Höpfl M; Bremer C; Schlaghecken R; Mehrens T; Assmann G; Schaefer RM
Nephrol Dial Transplant; 1999 Mar; 14(3):659-65. PubMed ID: 10193816
[TBL] [Abstract][Full Text] [Related]
9. Red cell ferritin, a marker of iron deficiency in hemodialysis patients.
Bhandari S; Owda AK; Kendall RG; Moran N; Norfolk DR; Brownjohn AM; Turney JH
Ren Fail; 1997 Nov; 19(6):771-80. PubMed ID: 9415934
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
Hasegawa M; Kawamura N; Koide S; Murase M; Asano S; Toba T; Kushimoto H; Murakami K; Tomita M; Hasegawa H; Shikano M; Mizuno M; Funahashi N; Kawashima S; Sugiyama S
Nihon Jinzo Gakkai Shi; 2002; 44(5):453-63. PubMed ID: 12216478
[TBL] [Abstract][Full Text] [Related]
11. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
12. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
13. Influence of intravenous iron therapy on novel markers of iron deficiency.
Chinnappa S; Bhandari S
Int J Artif Organs; 2010 May; 33(5):297-301. PubMed ID: 20593351
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Fishbane S; Shapiro W; Dutka P; Valenzuela OF; Faubert J
Kidney Int; 2001 Dec; 60(6):2406-11. PubMed ID: 11737617
[TBL] [Abstract][Full Text] [Related]
15. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy.
Asanuma M; Taguchi C; Uesaka H; Kumagai T; Seino K; Hosokawa H; Yamauchi F; Fujishima M; Murai K; Ishida Y
Lab Hematol; 2005; 11(2):124-30. PubMed ID: 16024336
[TBL] [Abstract][Full Text] [Related]
18. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
[TBL] [Abstract][Full Text] [Related]
19. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M
Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
[TBL] [Abstract][Full Text] [Related]
20. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
